Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Total Debt (2018 - 2025)

Volitionrx filings provide 10 years of Total Debt readings, the most recent being $6.7 million for Q4 2025.

  • On a quarterly basis, Total Debt rose 70.31% to $6.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.7 million, a 70.31% increase, with the full-year FY2025 number at $6.7 million, up 70.31% from a year prior.
  • Total Debt hit $6.7 million in Q4 2025 for Volitionrx, up from $5.9 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $6.7 million in Q4 2025 to a low of $2.8 million in Q3 2021.
  • Median Total Debt over the past 5 years was $3.8 million (2022), compared with a mean of $4.3 million.
  • Biggest five-year swings in Total Debt: fell 18.19% in 2024 and later skyrocketed 70.31% in 2025.
  • Volitionrx's Total Debt stood at $3.1 million in 2021, then grew by 25.33% to $3.8 million in 2022, then grew by 25.64% to $4.8 million in 2023, then decreased by 18.19% to $4.0 million in 2024, then skyrocketed by 70.31% to $6.7 million in 2025.
  • The last three reported values for Total Debt were $6.7 million (Q4 2025), $5.9 million (Q3 2025), and $6.4 million (Q2 2025) per Business Quant data.